ZTS

Zoetis Inc.

US StockNYSEPharmaceutical Preparations

Research the business. Follow the filings.

Financial information from SEC disclosures, with reporting periods kept in context.

Revenue

9.5B USDAnnual · FY 2025

Net income

2.7B USDAnnual · FY 2025

Total assets

15.5B USDAnnual · FY 2025

Equity

3.3B USDAnnual · FY 2025

Operating cash flow

2.9B USDAnnual · FY 2025

Revenue growth

2.3%Annual · FY 2025

ZTS · Chart

Chart provided by TradingView. Loading the chart connects your browser to TradingView and sends necessary technical information such as your IP address, page URL, and displayed symbol.

Reported financial information

Revenue

USD

9.5B USD

Period data
PeriodValue
FY 20217.8B USD
FY 20228.1B USD
FY 20238.5B USD
FY 20249.3B USD
FY 20259.5B USD

Operating income

USD

No applicable data available

No applicable data available

Net income

USD

2.7B USD

Period data
PeriodValue
FY 20212B USD
FY 20222.1B USD
FY 20232.3B USD
FY 20242.5B USD
FY 20252.7B USD

Total assets

USD

15.5B USD

Period data
PeriodValue
FY 202113.9B USD
FY 202214.9B USD
FY 202314.3B USD
FY 202414.2B USD
FY 202515.5B USD

Equity

USD

3.3B USD

Period data
PeriodValue
FY 20214.5B USD
FY 20224.4B USD
FY 20235B USD
FY 20244.8B USD
FY 20253.3B USD

Operating cash flow

USD

2.9B USD

Period data
PeriodValue
FY 20212.2B USD
FY 20221.9B USD
FY 20232.4B USD
FY 20243B USD
FY 20252.9B USD

Revenue growth

%

2.3%

Period data
PeriodValue
FY 202116.5%
FY 20223.9%
FY 20235.7%
FY 20248.3%
FY 20252.3%

Operating income growth

%

No applicable data available

No applicable data available

Net income growth

%

7.5%

Period data
PeriodValue
FY 202124.4%
FY 20223.8%
FY 202310.9%
FY 20246.1%
FY 20257.5%

Operating margin

%

No applicable data available

No applicable data available

Net margin

%

28.2%

Period data
PeriodValue
FY 202126.2%
FY 202226.2%
FY 202327.4%
FY 202426.9%
FY 202528.2%

Return on assets

%

18%

Period data
PeriodValue
FY 202114.8%
FY 202214.7%
FY 202316%
FY 202417.4%
FY 202518%

Debt/Equity

x

3.64x

Period data
PeriodValue
FY 20212.06x
FY 20222.39x
FY 20231.86x
FY 20241.98x
FY 20253.64x